Nomura Holdings’s Legend Biotech LEGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$433K Sell
15,000
-65,000
-81% -$1.75M ﹤0.01% 1546
2026
Q1
$1.45M Buy
80,000
+49,571
+163% +$945K ﹤0.01% 1032
2025
Q4
$662K Buy
+30,429
New +$872K ﹤0.01% 1447
2025
Q3
Sell
-27,961
Closed -$992K 1983
2025
Q2
$992K Buy
27,961
+19,840
+244% +$643K ﹤0.01% 1005
2025
Q1
$276K Buy
+8,121
New +$291K ﹤0.01% 1620
2024
Q2
Sell
-3,657
Closed -$205K 1899
2024
Q1
$205K Buy
+3,657
New +$221K ﹤0.01% 1462
2023
Q2
Sell
-6,955
Closed -$335K 1501
2023
Q1
$335K Sell
6,955
-25,457
-79% -$1.25M ﹤0.01% 1185
2022
Q4
$1.62M Buy
+32,412
New +$1.57M 0.01% 743
2022
Q3
Sell
-3,957
Closed -$215K 1836
2022
Q2
$215K Buy
+3,957
New +$167K ﹤0.01% 1270
2022
Q1
Sell
-136,132
Closed -$6.34M 2221
2021
Q4
$6.34M Buy
136,132
+5,500
+4% +$279K 0.02% 624
2021
Q3
$6.17M Hold
130,632
0.02% 559
2021
Q2
$5.33M Buy
+130,632
New +$4.44M 0.01% 555
2021
Q1
Sell
-130,632
Closed -$3.85M 2118
2020
Q4
$3.85M Sell
130,632
-45
-0% -$1.29K 0.01% 643
2020
Q3
$4.04M Buy
+130,677
New +$4.4M 0.01% 515

Other funds holding LEGN

Nomura Holdings's LEGN Position: Q2 2026 in Review

Nomura Holdings reduced its Legend Biotech (LEGN) stake by 81% in Q2 2026, selling an estimated $1.75M and leaving 15,000 shares worth $433K. The position accounts for ﹤0.01% of the portfolio, ranked #1546.

Nomura Holdings first reported a position in LEGN in Q3 2020 and has held it in 14 quarters since. The position peaked at $6.34M in Q4 2021. 201 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • Nomura Holdings held 15,000 shares of Legend Biotech worth $433K as of Q2 2026.
  • Nomura Holdings sold 65,000 Legend Biotech shares in Q2 2026, an estimated $1.75M.
  • Legend Biotech made up ﹤0.01% of Nomura Holdings's portfolio in Q2 2026, its #1546 holding.
  • Nomura Holdings first reported a position in Legend Biotech in Q3 2020 and has held it in 14 quarters since.
  • Nomura Holdings's Legend Biotech position peaked at $6.34M in Q4 2021.
  • 201 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Nomura Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.